BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16507885)

  • 1. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
    Tardito D; Perez J; Tiraboschi E; Musazzi L; Racagni G; Popoli M
    Pharmacol Rev; 2006 Mar; 58(1):115-34. PubMed ID: 16507885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor.
    Vinet J; Carra S; Blom JM; Brunello N; Barden N; Tascedda F
    Neuropharmacology; 2004 Dec; 47(7):1062-9. PubMed ID: 15555640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production.
    Hisaoka K; Maeda N; Tsuchioka M; Takebayashi M
    Brain Res; 2008 Feb; 1196():53-8. PubMed ID: 18234163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant action: to the nucleus and beyond.
    Malberg JE; Blendy JA
    Trends Pharmacol Sci; 2005 Dec; 26(12):631-8. PubMed ID: 16246434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upregulation of plasticity-related proteins following TBI is disrupted with acute voluntary exercise.
    Griesbach GS; Gomez-Pinilla F; Hovda DA
    Brain Res; 2004 Aug; 1016(2):154-62. PubMed ID: 15246851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout.
    Musazzi L; Perez J; Hunt SP; Racagni G; Popoli M
    Eur J Neurosci; 2005 Mar; 21(5):1370-8. PubMed ID: 15813946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylate alters the expression of calcium response transcription factor 1 in the cochlea: implications for brain-derived neurotrophic factor transcriptional regulation.
    Singer W; Panford-Walsh R; Watermann D; Hendrich O; Zimmermann U; Köpschall I; Rohbock K; Knipper M
    Mol Pharmacol; 2008 Apr; 73(4):1085-91. PubMed ID: 18198284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
    Manna PR; Chandrala SP; Jo Y; Stocco DM
    J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a biphasic signaling pathway involved in ischemic resistance of the hippocampal dentate gyrus.
    Blanquet PR; Mariani J; Fournier B
    Exp Neurol; 2006 Dec; 202(2):357-72. PubMed ID: 16996500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
    Cereseto M; Ferrero A
    Vertex; 2003; 14(51):30-5. PubMed ID: 12690407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying activity-dependent regulation of BDNF expression.
    Shieh PB; Ghosh A
    J Neurobiol; 1999 Oct; 41(1):127-34. PubMed ID: 10504200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
    Calin-Jageman IE; Wang J; Bannon MJ
    J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal interaction of serotonin and neuronal activity in regulation of cAMP-responsive element-dependent gene expression.
    Mahgoub MA; Sara Y; Kavalali ET; Monteggia LM
    J Pharmacol Exp Ther; 2006 Apr; 317(1):88-96. PubMed ID: 16382023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R; Zhang X; Yang J; Li Y; Liu Y
    J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina.
    Azadi S; Johnson LE; Paquet-Durand F; Perez MT; Zhang Y; Ekström PA; van Veen T
    Brain Res; 2007 Jan; 1129(1):116-29. PubMed ID: 17156753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala.
    Reagan LP; Hendry RM; Reznikov LR; Piroli GG; Wood GE; McEwen BS; Grillo CA
    Eur J Pharmacol; 2007 Jun; 565(1-3):68-75. PubMed ID: 17368617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan.
    Pradines E; Loubet D; Schneider B; Launay JM; Kellermann O; Mouillet-Richard S
    Cell Signal; 2008 Nov; 20(11):2050-8. PubMed ID: 18718863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic effects of antidepressant drugs.
    Castrén E
    Curr Opin Pharmacol; 2004 Feb; 4(1):58-64. PubMed ID: 15018840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.